These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 12639367)
1. Failure of tibolone to potentiate the pharmacological effect of fluoxetine in postmenopausal major depression. Berlanga C; Mendieta D; Alva G; del Carmen Lara M J Womens Health (Larchmt); 2003; 12(1):33-9. PubMed ID: 12639367 [TBL] [Abstract][Full Text] [Related]
2. Tibolone improves depression in women through the menopause transition: A double-blind randomized controlled trial of adjunctive tibolone. Kulkarni J; Gavrilidis E; Thomas N; Hudaib AR; Worsley R; Thew C; Bleeker C; Gurvich C J Affect Disord; 2018 Aug; 236():88-92. PubMed ID: 29723767 [TBL] [Abstract][Full Text] [Related]
3. Tibolone in postmenopausal women with systemic lupus erythematosus: a pilot study. Vieira CS; Pereira FV; de Sá MF; Paulo LJ; Martins WP; Ferriani RA Maturitas; 2009 Mar; 62(3):311-6. PubMed ID: 19193505 [TBL] [Abstract][Full Text] [Related]
4. A randomized, placebo-controlled, crossover study of tibolone (Livial) on menopause symptoms, psychological well-being, and dyadic relationship of postmenopausal Chinese women and their spouses. Lam PM; Cheung GW; Shek DT; Lee DT; Haines CJ; Chung TK Menopause; 2004; 11(4):416-22. PubMed ID: 15243279 [TBL] [Abstract][Full Text] [Related]
5. Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone, SERMs and estrogen (+/-progestogen) treatments. Kloosterboer HJ; Ederveen AG J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):157-65. PubMed ID: 12650712 [TBL] [Abstract][Full Text] [Related]
6. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study. Polisseni AF; Andrade AT; Ribeiro LC; Castro IQ; Brandão M; Polisseni F; Guerra Mde O Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326 [TBL] [Abstract][Full Text] [Related]
7. Short and long term effects of tibolone in postmenopausal women. Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846 [TBL] [Abstract][Full Text] [Related]
10. Effects of low dose of tibolone on steroid receptors and Bcl-2 on the postmenopausal endometrium. Reis BF; Lima SM; Silva GM; Francisco AM; Barbosa LC; Archangelo SC; Grande RM Histol Histopathol; 2016 Jun; 31(6):629-34. PubMed ID: 26670665 [TBL] [Abstract][Full Text] [Related]
11. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes. Barbosa L; Berk M; Vorster M J Clin Psychiatry; 2003 Apr; 64(4):403-7. PubMed ID: 12716240 [TBL] [Abstract][Full Text] [Related]
12. Venlafaxine vs. fluoxetine in postmenopausal women with major depressive disorder: an 8-week, randomized, single-blind, active-controlled study. Zhou J; Wang X; Feng L; Xiao L; Yang R; Zhu X; Shi H; Hu Y; Chen R; Boyce P; Wang G BMC Psychiatry; 2021 May; 21(1):260. PubMed ID: 34011310 [TBL] [Abstract][Full Text] [Related]
13. Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. Emslie GJ; Heiligenstein JH; Wagner KD; Hoog SL; Ernest DE; Brown E; Nilsson M; Jacobson JG J Am Acad Child Adolesc Psychiatry; 2002 Oct; 41(10):1205-15. PubMed ID: 12364842 [TBL] [Abstract][Full Text] [Related]
14. Does estrogen enhance the antidepressant effects of fluoxetine? Westlund Tam L; Parry BL J Affect Disord; 2003 Oct; 77(1):87-92. PubMed ID: 14550939 [TBL] [Abstract][Full Text] [Related]
15. Effects of tibolone on abdominal subcutaneous fat, serum leptin levels, and anthropometric indices: a 6-month, prospective, randomized, placebo-controlled, double-blind study. Odabasi AR; Yuksel H; Kafkas S; Demircan S; Karul A; Kozaci D; Koseoglu K; Onur E Adv Ther; 2006; 23(6):926-37. PubMed ID: 17276962 [TBL] [Abstract][Full Text] [Related]
16. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women. Ziaei S; Moghasemi M; Faghihzadeh S Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119 [TBL] [Abstract][Full Text] [Related]
17. Effects of tibolone and raloxifene on health-related quality of life and sexual function. Nijland EA; Weijmar Schultz WC; Davis SR Maturitas; 2007 Oct; 58(2):164-73. PubMed ID: 17870260 [TBL] [Abstract][Full Text] [Related]
18. [Comparison of different antidepression therapy in perimenopausal and postmenopausal women with depression]. Lai AL; Zhao YW; Qi HY; Zhang JS; Zhang LS; Weng YQ Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):169-72. PubMed ID: 17537301 [TBL] [Abstract][Full Text] [Related]
19. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study. Langer RD; Landgren BM; Rymer J; Helmond FA; Am J Obstet Gynecol; 2006 Nov; 195(5):1320-7. PubMed ID: 16875644 [TBL] [Abstract][Full Text] [Related]
20. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. Judd LL; Rapaport MH; Yonkers KA; Rush AJ; Frank E; Thase ME; Kupfer DJ; Plewes JM; Schettler PJ; Tollefson G Am J Psychiatry; 2004 Oct; 161(10):1864-71. PubMed ID: 15465984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]